GLP-1 medications prescribed for type 2 diabetes, including Ozempic (semaglutide), Mounjaro (tirzepatide), and Victoza (liraglutide), continue to receive coverage under most BCBS plans
The reason for this is unknown, but prolonged exogenous stimulation of hormone-specific receptors may influence endogenous hormonal regulation (17)
Though still investigational, several sham-controlled, randomized clinical trials suggest benefits in mild-to-moderate ED from shockwave therapy
At Atlanta Bariatrics, we offer personalized weight loss and wellness plans that may include these innovative medications
American Association of Clinical Endocrinology and Endocrine Society clinical practice guideline for pharmacological management of obesity
10.1001/arch-neur.64.4.485 55